{"schema_version":"1","generated_at":"2026-10-29T18:59:53.824Z","data_as_of":null,"url":"https://www.findmykol.com/kol/namrata-vijayvergia","json_url":"https://www.findmykol.com/kol/namrata-vijayvergia/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"namrata-vijayvergia","name":"Namrata Vijayvergia","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Fox Chase Cancer Center","institution_url":"https://www.findmykol.com/institution/fox-chase-cancer-center","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1871741025","orcid":"0000-0001-6469-4759","openalex":"A5045353148"},"summary":"Namrata Vijayvergia is an Oncology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 132 publications with 2,461 citations (h-index 20); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":132,"cited_by_count":2461,"h_index":20,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07167446","title":"Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy","phase":"EARLY_PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07167446","trial_url":"https://www.findmykol.com/trial/NCT07167446"},{"nct":"NCT03099486","title":"Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03099486","trial_url":"https://www.findmykol.com/trial/NCT03099486"},{"nct":"NCT02939651","title":"A Study of Pembrolizumab in Patients With Neuroendocrine Tumors","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02939651","trial_url":"https://www.findmykol.com/trial/NCT02939651"}],"source":"trials"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":9102.5,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871741025"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":7000,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871741025"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":6919.58,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871741025"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1871741025","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2020,"last":2025},"rows_total":3,"shown":3,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21CA292276","title":"Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study","fiscal_year":2025,"amount_usd":"429162","organization":"RESEARCH INST OF FOX CHASE CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R21CA292276"},{"project":"R03CA219722","title":"Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors","fiscal_year":2021,"amount_usd":"92150","organization":"RESEARCH INST OF FOX CHASE CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R03CA219722"},{"project":"R03CA219722","title":"Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors","fiscal_year":2020,"amount_usd":"92150","organization":"RESEARCH INST OF FOX CHASE CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R03CA219722"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline","year":2025,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op-25-00133","status":"verified"},{"title":"Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases","year":2025,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-025-17363-0","status":"verified"},{"title":"Gastroenteropancreatic Neuroendocrine Tumors","year":2025,"journal":"Gastroenterology","source_url":"https://doi.org/10.1053/j.gastro.2025.07.004","status":"verified"},{"title":"Efficacy and safety of cabozantinib for advanced gastrointestinal (GI) neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of the phase 3 CABINET trial (Alliance A021602).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.666","status":"verified"},{"title":"Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms","year":2025,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-025-17360-3","status":"verified"}],"source":"works"},"contact":{"address_1":"333 COTTMAN AVE","city":"Philadelphia","state":"PA","zip":"191112434","phone":"215-728-6900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1871741025","source":"identity"},"similar":[{"name":"Elizabeth Plimack","slug":"elizabeth-plimack","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/elizabeth-plimack","json_url":"https://www.findmykol.com/kol/elizabeth-plimack/profile.json"},{"name":"Martin Edelman","slug":"martin-edelman","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/martin-edelman","json_url":"https://www.findmykol.com/kol/martin-edelman/profile.json"},{"name":"Shazia Nakhoda","slug":"shazia-nakhoda","institution":"Fox Chase Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/shazia-nakhoda","json_url":"https://www.findmykol.com/kol/shazia-nakhoda/profile.json"},{"name":"Hossein Borghaei","slug":"hossein-borghaei","institution":"Fox Chase Cancer Center","specialty":"Magnetic Resonance Imaging (MRI)","url":"https://www.findmykol.com/kol/hossein-borghaei","json_url":"https://www.findmykol.com/kol/hossein-borghaei/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":27,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-04-09","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}